Maxcyte, Inc.
MXCT- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001287098
No open-market purchases or sales by Maxcyte, Inc. insiders were filed in the last 90 days; 122 institutions reported holding it in 13F filings for Q2 2026, worth $78.0M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Maxcyte, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 116
- +1 vs. Q1 2023
- Shares held
- 66.1M
- −527.5K (−0.8%) vs. Q1 2023
- Total value
- $303.3M
- −$24.6M (−7.5%) vs. Q1 2023
- New holders
- 12
- 48 more added
- Sold out
- 11
- 36 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MXCT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 122 | $78.0M |
| Q1 2026 | 132 | $46.2M |
| Q4 2025 | 112 | $98.0M |
| Q3 2025 | 112 | $110.8M |
| Q2 2025 | 120 | $155.5M |
| Q1 2025 | 115 | $193.8M |
| Q4 2024 | 119 | $301.9M |
| Q3 2024 | 120 | $267.4M |
| Q2 2024 | 114 | $268.0M |
| Q1 2024 | 124 | $280.8M |
| Q4 2023 | 121 | $316.1M |
| Q3 2023 | 120 | $200.8M |
| Q2 2023 | 116 | $303.3M |
| Q1 2023 | 115 | $327.9M |
| Q4 2022 | 105 | $377.7M |
| Q3 2022 | 109 | $453.8M |
| Q2 2022 | 104 | $322.7M |
| Q1 2022 | 99 | $479.8M |
| Q4 2021 | 104 | $683.6M |
| Q3 2021 | 81 | $665.4M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Maxcyte, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Portolan Capital Management, LLC | 1,649,877 | $7.57M | 0.67% | +1,028,263+165.4% | Added |
| American Century Companies Inc | 1,708,861 | $7.84M | 0.01% | +23,670+1.4% | Added |
| Geode Capital Management, LLC | 1,794,652 | $8.24M | 0.00% | +115,276+6.9% | Added |
| State Street Corp | 1,812,374 | $8.32M | 0.00% | +18,225+1.0% | Added |
| First Light Asset Management, LLC | 1,857,566 | $8.53M | 0.67% | +493,344+36.2% | Added |
| Blue Water Life Science Advisors, LLC | 1,885,000 | $8.65M | 5.84% | −1,340,000−41.6% | Reduced |
| Granahan Investment Management Inc | 1,891,888 | $8.68M | 0.27% | +1,183,731+167.2% | Added |
| Millennium Management LLC | 1,936,992 | $8.89M | 0.01% | −910,161−32.0% | Reduced |
| Massachusetts Financial Services Co | 1,949,375 | $8.95M | 0.00% | −18,866−1.0% | Reduced |
| Holocene Advisors, LP | 2,117,228 | $9.72M | 0.04% | 00.0% | Unchanged |
| ArrowMark Colorado Holdings LLC | 2,576,260 | $11.8M | 0.13% | +277,186+12.1% | Added |
| Stonepine Capital Management, LLC | 3,966,916 | $18.2M | 6.57% | +1,259,826+46.5% | Added |
| Casdin Capital, LLC | 4,715,000 | $21.6M | 1.89% | −210,000−4.3% | Reduced |
| Vanguard Group Inc | 4,970,930 | $22.8M | 0.00% | +82,457+1.7% | Added |
| Vitruvian Partners LLP | 5,043,356 | $23.1M | 4.71% | 00.0% | Unchanged |
| BlackRock Inc. | 6,920,084 | $31.8M | 0.00% | −100,577−1.4% | Reduced |
| Bamco Inc | 0 | $0 | 0.00% | −1,987,904−100.0% | Sold out |
| AWM Investment Company, Inc. | 0 | $0 | 0.00% | −500,000−100.0% | Sold out |
| Baillie Gifford & Co | 0 | $0 | 0.00% | −293,325−100.0% | Sold out |
| J. Goldman & Co LP | 0 | $0 | 0.00% | −175,000−100.0% | Sold out |
| Tamarack Advisers, LP | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| DekaBank Deutsche Girozentrale | 0 | $0 | 0.00% | −38,500−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −35,516−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −33,155−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −16,883−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −12,750−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −3,974−100.0% | Sold out |